In the less developed countries, most people do not have sufficient access to essential medicines. Generic medicines play an important role in increasing access to essential medical products, since they can be 20–90% cheaper than their branded equivalents. Generic medicines are therefore a key element to consider in many countries’ health policies and systems. The increasing global and regional demand for generics, driven by government policies and cost-effective strategies, create a significant opportunity for generic manufacturers around the world. This case study seeks to analyse the use of generic drugs in the Middle East and in so doing also unveil the nature of the generic drugs market in the Middle East, and specifically Iraq.
SharmaP, et al.
Opportunities for generic drugs in India. Int J Third World Med2008;
8: 1–8.
3.
DadhichAUpadhyayaM.A review: exploring branded generic drugs by Indian pharmaceutical multinational companies as a new prospect. Pharmacophore2011;
2: 271–275.
4.
KaplanWA and WirtzV.A research agenda to promote affordable and quality assured medicines.J Pharmac Policy Pract2014;
2: 1–3.
5.
SalimAMA and MulhollandG.Examining the reasons behind the success of the generic pharmaceutical companies: the case of Sudan market.Middle East J Business2015;
10: 59–64.
6.
AlbrechtMHoerAZimmermannA.Value of generic medicines: as health economics study. J Pharm Policy Pract2015;
8(Suppl 1): 15.
7.
HaqueM.Generic medicine and prescribing: a quick assessment. Adv Hum Biol2017;
7: 101–108.
BeraAMukherjeeA.The importance of generic drugs in India.Int J Pharm Chem Biol Sci2012;
2: 575–587.
11.
HassaliMA, et al.
The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J2014;
22: 491–503.
12.
ChawlaK, et al.
A global comparison between brand-name and generic drugs.Ind J Pharm Pract2014;
7: 23–28.
13.
GalaniV.Choice of better medicine in India: branded vs generic medicine. Pharm Pharmacol Int J2017;
5: 124–125.
LeeC-Y, et al.
Forces influencing generic drug development in the United States: a narrative review. J Pharmac Policy Pract2016;
9: 26.
17.
PiccinniC, et al.
The generic medicines system in Italy: scenarios for sustainable growth. Generics Biosimilars Initiat J2016;
3: 114–122.
18.
KulikovskaSI, et al.
Use of generic medicines in Latvia: awareness, opinions and experiences of the population.J Pharmac Policy Pract2019;
12: 1.
19.
AuroraJ.Generic industry opportunities and challenges for emerging markets: an overview.Asia Pacific Biotech News2011;
15: 32–34.
20.
MathewP.Generic drugs: review and experiences from South India.J Fam Med Primary Care20154: 319–323.
21.
Singh, et al.
Beliefs and attitudes of generic versus original drugs among doctors in a tertiary-care hospital in Western India.Nat J Physiol Pharm Pharmacol2016;
6: 276–281.
22.
El-JardaliFFadlallahRMorsiR, et al.
Pharmacists’ views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study.Implement Sci2017;
12: 23.
23.
ButlerD.Iran hit by drug shortage. Nature2013;
504: 15–16.
IFPMA. The pharmaceutical industry and global health: facts and figures 2017, International Federation of Pharmaceutical Manufacturers & Associations, Switzerland, www.ifpma.org (accessed 16 March 2020).
